Cryptococcus gattii is the main etiological agent of
cryptococcosis in immunocompetent individuals. The
triazole drug itraconazole is one of the antifungals used to treat patients with
cryptococcosis. Heteroresistance is an adaptive mechanism to counteract the stress of increasing
drug concentrations, and it can enhance the ability of a microorganism to survive under antifungal pressure. In this study, we evaluated the ability of 11 C. gattii strains to develop
itraconazole heteroresistance. Heteroresistant clones were analyzed for
drug susceptibility, alterations in cell diameter,
capsule properties, and virulence in a murine model. Heteroresistance to
itraconazole was intrinsic in all of the strains analyzed, reduced both the
capsule size and the cell diameter, induced molecular heterogeneity at the chromosomal level, changed the negatively charged cells, reduced
ergosterol content, and improved the
antioxidant system. A positive correlation between surface/volume ratio of original cells and the level of heteroresistance to
itraconazole (LHI) was observed in addition to a negative correlation between
capsule size of heteroresistant clones and LHI. Moreover, heteroresistance to
itraconazole increased the engulfment of C. gattii by macrophages and augmented fungal proliferation inside these cells, which probably accounted for the reduced survival of the mice infected with the heteroresistant clones and the higher fungal burden in lungs and brain. Our results indicate that heteroresistance to
itraconazole is intrinsic and increases the virulence of C. gattii. This phenomenon may represent an additional mechanism that contributes to relapses of
cryptococcosis in patients during
itraconazole therapy.